{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/KYNB/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"KYNB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KYNB\",,,,,undefined,":{"symbol":"KYNB","market":"US","secType":"STK","nameCN":"Kyntra Bio Inc","latestPrice":7.67,"timestamp":1771427755163,"preClose":7.33,"halted":0,"volume":708,"delay":0,"changeRate":0.04638472032742154,"floatShares":3623701,"shares":4045445,"eps":53.37957,"marketStatus":"Trading","change":0.34,"latestTime":"02-18 10:30:04 EST","open":7.67,"high":7.67,"low":7.67,"amount":5371.30926,"amplitude":0,"askPrice":7.79,"askSize":116,"bidPrice":7.42,"bidSize":200,"shortable":3,"etf":0,"ttmEps":53.37957,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1771448400000},"marketStatusCode":2,"adr":0,"listingDate":1415941200000,"exchange":"NASDAQ","adjPreClose":7.33,"preHourTrading":{"tag":"盘前","latestPrice":7.56,"preClose":7.33,"latestTime":"09:27 EST","volume":386,"amount":2909.1223118,"timestamp":1771424860048,"change":0.23,"changeRate":0.031378,"amplitude":0.053315},"postHourTrading":{"tag":"盘后","latestPrice":7.33,"preClose":7.33,"latestTime":"19:38 EST","volume":14,"amount":102.61,"timestamp":1771375100005,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.131751},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KYNB\",,,,,undefined,":{"symbol":"KYNB","floatShares":3623701,"roa":"-18.42%","roe":"--","lyrEps":-11.889518,"volumeRatio":0.131751,"shares":4045445,"dividePrice":0,"high":7.67,"amplitude":0,"preClose":7.33,"low":7.67,"week52Low":4.85,"pbRate":"-1.82","psRate":"3.74","week52High":21.9375,"institutionHeld":0,"latestPrice":7.67,"committee":0.265823,"eps":53.37957,"divideRate":0,"volume":708,"delay":0,"ttmEps":53.37957,"open":7.67,"prevYearClose":8.78,"prevWeekClose":7.45,"prevMonthClose":7.88,"prevQuarterClose":8.78,"fiveDayClose":7.78,"twentyDayClose":8.55,"sixtyDayClose":8.55},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/KYNB\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"KYNB\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"KYNB\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.5,"hold":0.5,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5,"analysts":2,"updateTime":1734757200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/KYNB\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"KYNB","date":"2026-02-17","current":0.137318,"percent":0,"low":0.139754,"twenty":0.146995,"median":0.160014,"eighty":0.171044,"high":0.18215,"avg":0.159475,"sd":0.012339,"marketCap":30138565},"quantilePoints":[{"date":"2026-01-09","current":0.17821,"twenty":0.178998,"median":0.18018,"eighty":0.181362,"marketCap":38431727},{"date":"2026-01-16","current":0.170144,"twenty":0.170369,"median":0.172958,"eighty":0.17821,"marketCap":36692186},{"date":"2026-01-23","current":0.168268,"twenty":0.168268,"median":0.171269,"eighty":0.17821,"marketCap":36287641},{"date":"2026-01-30","current":0.150259,"twenty":0.160389,"median":0.169206,"eighty":0.172958,"marketCap":32404014},{"date":"2026-02-06","current":0.140692,"twenty":0.153073,"median":0.163953,"eighty":0.171457,"marketCap":30340837},{"date":"2026-02-13","current":0.140317,"twenty":0.147445,"median":0.160201,"eighty":0.171269,"marketCap":30259928},{"date":"2026-02-17","current":0.139754,"twenty":0.146995,"median":0.160014,"eighty":0.171044,"marketCap":30138565}],"updateTime":1771415861526},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"KYNB\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2612460571","title":"Kyntra Bio to Present at Oppenheimer and Leerink Healthcare Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2612460571","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612460571?lang=en_us&edition=fundamental","pubTime":"2026-02-18 05:05","pubTimestamp":1771362323,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kyntra Bio Inc. published the original content used to generate this news brief via GlobeNewswire  on February 17, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260217:nNDL86fzdC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KYNB","LU2210149790.SGD","LU0314104364.USD","SG9999014039.USD","BK4112","SG9999014005.SGD","SG9999014013.SGD","BK4585","IE00BKPKM429.USD","LU2095319765.USD","BK4139","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","BK4588","SG9999014021.USD","LU2210150020.SGD","IE00B64PRP62.GBP","NDAQ"],"gpt_icon":0},{"id":"2605314911","title":"Kyntra Bio Highlights Pipeline Progress in Prostate Cancer and Anemia Therapies in New Corporate Presentation","url":"https://stock-news.laohu8.com/highlight/detail?id=2605314911","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605314911?lang=en_us&edition=fundamental","pubTime":"2026-01-21 05:05","pubTimestamp":1768943107,"startTime":"0","endTime":"0","summary":"Kyntra Bio Inc. has provided an update on its recent corporate activities and clinical development programs. The company completed the sale of FibroGen China to AstraZeneca for approximately $220 million and repaid its term loan to Morgan Stanley Tactical Value. These actions have extended the company’s cash runway into 2028. Kyntra Bio highlighted progress with its oncology pipeline, including the initiation of a Phase 2 trial for FG-3246, a CD46-targeting antibody-drug conjugate , and FG-3180, a PET imaging agent, in metastatic castration-resistant prostate cancer . Interim results from this trial are expected in the second half of 2026. The presentation also noted the high unmet need for new treatment options in late-stage prostate cancer and described YS5FL, a fully-human monoclonal antibody targeting CD46, as part of its approach to developing more targeted therapies for mCRPC. You can access the full presentation through the link below.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260120:nNDL7GfTTp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0972486137.USD","LU0964806797.USD","LU0047473722.EUR","LU1003077747.HKD","LU2114397693.USD","LU0266013472.USD","BK4139","LU0345777147.USD","LU1814569148.SGD","LU0557290698.USD","LU1015430645.USD","LU1989771016.USD","LU2293690082.USD","LU0310800379.SGD","LU0640478417.SGD","LU1019632923.USD","SGXZ57979304.SGD","LU0011850046.USD","SG9999001176.SGD","LU0345777659.USD","LU0757432116.USD","AZN.UK","LU1078025761.USD","LU0784385840.USD","LU0553294199.USD","LU0784384876.USD","LU0158827948.USD","LU2293690249.USD","LU2089284900.SGD","IE00BFTCPJ56.SGD","LU1119994496.HKD","LU1261432733.SGD","LU0058720904.USD","LU0114720955.EUR","LU0889566641.SGD","LU0784385170.HKD","LU0310800965.SGD","LU0920840948.USD","IE0009355771.USD","LU0499090636.EUR","LU1481600234.SGD","KYNB","LU1496350171.SGD","LU1880407132.USD","LU0957799991.USD","LU0077335932.USD","LU1019634622.SGD","LU0889565080.SGD","03165","LU0289739699.SGD"],"gpt_icon":0},{"id":"2601808565","title":"FibroGen Inc - Kyntra Bio to Trade Under Symbol 'Kynb' January 8","url":"https://stock-news.laohu8.com/highlight/detail?id=2601808565","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601808565?lang=en_us&edition=fundamental","pubTime":"2026-01-07 20:30","pubTimestamp":1767789050,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260107:nFWN3Y80SP:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["FGEN","BK4505","BK4139","KYNB"],"gpt_icon":0},{"id":"2601545808","title":"FibroGen Rebrands as Kyntra Bio","url":"https://stock-news.laohu8.com/highlight/detail?id=2601545808","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601545808?lang=en_us&edition=fundamental","pubTime":"2026-01-07 20:30","pubTimestamp":1767789017,"startTime":"0","endTime":"0","summary":"FibroGen Inc. has announced a rebranding to Kyntra Bio, reflecting a new focus on developing novel therapies for oncology and rare diseases. The company will now trade on Nasdaq under the symbol \"KYNB.\". Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. FibroGen Inc. published the original content used to generate this news brief via GlobeNewswire  on January 07, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260107:nNDL7rLmSk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","LU2210150020.SGD","NDAQ","SG9999014039.USD","IE00B64PRP62.GBP","LU0314104364.USD","KYNB","BK4588","BK4139","IE00BGHQF748.EUR","FGEN","LU2095319765.USD","BK4505","SG9999014005.SGD","IE00B3QW5Z07.USD","BK4585","IE00BKPKM429.USD","SG9999014021.USD","SG9999014013.SGD","LU2210149790.SGD"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":4,"code":"91000000","status":"200"}]}}